Vernakalant hydrochloride for rapid conversion of atrial fibrillation. A phase 3, randomized, placebo-controlled trial
被引:0
|
作者:
Estes, N. A. Mark, III
论文数: 0引用数: 0
h-index: 0
机构:
Tufts Univ, Sch Med, Dept Med, Div Cardiol,New England Cardiac Arrhythmia Ctr, Boston, MA 02111 USATufts Univ, Sch Med, Dept Med, Div Cardiol,New England Cardiac Arrhythmia Ctr, Boston, MA 02111 USA
Estes, N. A. Mark, III
[1
]
机构:
[1] Tufts Univ, Sch Med, Dept Med, Div Cardiol,New England Cardiac Arrhythmia Ctr, Boston, MA 02111 USA